Atomwise Interview Guide

Atomwise is a pioneering TechBio company that harnesses the power of artificial intelligence and machine learning to revolutionize small molecule drug discovery. With its cutting-edge deep learning technologies, Atomwise has developed a state-of-the-art AI discovery and optimization engine that excels in structure-based drug design, enabling the identification and refinement of novel chemical entities. The company has successfully raised over $174 million from leading venture capital firms, underscoring its commitment to creating innovative medicines that aim to improve patient care, particularly in the field of immunology. Atomwise is dedicated to fostering an inclusive workplace that values diverse perspectives, recognizing that such diversity is essential in effectively addressing the healthcare needs of a wide range of populations.